MET and urinary bladder carcinoma: Two patients (P003 and P006) who met Amsterdam criteria, whose families suffered from colorectal cancer, lung cancer and bladder cancer, were not identified as MMR mutation carriers, but they carried many other tumor-associated genes, such as BRCA2, CDH1, MET, ATM, NF1.